Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;33(12):2543-5.
doi: 10.2337/dc10-0862. Epub 2010 Aug 30.

Implementing a state-based cardiovascular disease and diabetes prevention program

Karl K Vanderwood  1 , Taryn O Hall, Todd S Harwell, Marcene K Butcher, Steven D Helgerson; Montana Cardiovascular Disease and Diabetes Prevention Program Workgroup
Collaborators, Affiliations

Implementing a state-based cardiovascular disease and diabetes prevention program

Karl K Vanderwood et al. Diabetes Care. 2010 Dec.

Abstract

Objective: To evaluate weight loss and cardiometabolic risk reduction achieved through an adapted Diabetes Prevention Program intervention among adults at high risk for cardiovascular disease (CVD) and diabetes.

Research design and methods: Eight health care facilities implemented a group-based lifestyle intervention beginning in 2008. Participants attended 16 weekly core sessions followed by 6 monthly after core sessions.

Results: A total of 1,003 participants were enrolled, 816 (81%) completed the core and 578 (58%) completed the after core. Of participants completing the core and after core, 45 and 49% achieved the 7% weight loss goal, respectively. There were significant improvements in blood pressure, fasting glucose, and LDL cholesterol among participants completing the intervention.

Conclusions: Our findings indicate it is feasible for state-coordinated CVD and diabetes prevention programs to achieve significant weight loss and improve cardiometabolic risk.

PubMed Disclaimer

References

    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403 - PMC - PubMed
    1. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M: Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005;28:888–894 - PMC - PubMed
    1. Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyövälti E, Tuomilehto J: National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 2007;66:101–112 - PubMed
    1. Schwarz PEH, Reddy P, Greaves CJ, J, Dunbar JA, Schwarz J: Diabetes Prevention in Practice. Dresden, Germany, TUMAINI Institute for Prevention Management, 2010, p. 45–56
    1. Schwarz PE, Lindström J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J: The European perspective of type 2 diabetes prevention: diabetes in Europe—prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008;116:167–172 - PubMed

Publication types